Portal de Oportunidades de Pesquisa – POP – Propesq

Objetivo:
The Cystic Fibrosis Foundation Therapeutics Inc. (CFFT) Therapeutics Development Award (TDA) program is designed to stimulate businesses to pursue novel therapies for cystic fibrosis by filling the gap between basic research and Phase 3 clinical trials. The program provides companies with funding and other resources to support studies that may include drug discovery, pre-clinical safety, PK/PD, and ADME testing through early safety and efficacy trials in patients.

Inscrições:
até dia 31 de outubro de 2017.

Mais informações no site.

Objetivo:
As the world s largest computing society, the Association for Computing Machinery (ACM) strengthens the professions collective voice through strong leadership, promotion of the highest standards, and recognition of technical excellence. ACM supports the professional growth of its members by providing opportunities for life?long learning, career development, and professional networking. ACM established the Doctoral Dissertation Award program to recognize and encourage superior research and writing by doctoral candidates in computer science and engineering.

Inscrições:
até dia 21 de outubro de 2017.

Mais informações no site.

Evento:
2018 International Conference on Applied Mathematics and Computational Physics

Data:
de 19 a 21 de janeiro de 2018.

Inscrições:
até 31 de outubro de 2017.

Local:
Budapeste, Hungria.

Mais informações no site.

Objetivo:
The Funding Opportunity Announcement (FOA) encourages the submission of investigator-initiated research grant applications to support the secondary analysis of existing data sets with the goal of enhancing our understanding of patterns of alcohol consumption, the epidemiology and etiology, including genetics, of alcohol-related problems. Research grants for the Secondary Analyses of Existing Alcohol Research Data are intended to provide support for studies that utilize currently available data sets to increase our understanding of the incidence, prevalence and etiology of alcohol related problems and disorders in the population, as well as the risk and protective factors associated with them.

Inscrições:
R01: October 05, 2017;
R03: October 16, 2017.

Letter of Intent Due Date(s):
30 days prior to the application due date.

Data de expiração:
September 8, 2020.

Mais informações em R01 e R03.

Objetivo:
The purpose of the Funding Opportunity Announcement (FOA) is to support the development of chemical probes that aid basic research investigations on substance use disorders (SUDs) or identify new lead chemical scaffolds with potential for structure activity relationship (SAR) studies on SUDs. In the long term, it is hoped that these lead chemical scaffolds will provide a greater number of pharmacological tools for basic research and possible drug candidates for medications development.

Inscrições:
R21/R33: October 16, 2017.

Letter of Intent Due Date(s):
30 days prior to the application due date.

Data de expiração:
September 8, 2019.

Mais informações no site.

Objetivo:
The overall goal of this funding opportunity announcement (FOA) is to encourage the submission of research grant applications to investigate the molecular mechanisms by which oncogenic fusion genes and their gene products contribute to pediatric sarcoma initiation, progression, and metastasis. Better understanding of the molecular pathways activated by chromosomal translocations in pediatric sarcomas, and their relationship to oncogenesis and tumor progression, can elucidate mechanisms of cancer pathogenesis and potentially lead to novel therapeutics.

Inscrições:
R01: October 05, 2017;
R21: October 16, 2017.

Letter of Intent Due Date(s):
30 days prior to the application due date.

Data de expiração:
May 8, 2020.

Mais informações em R01 e R21.

Objetivo:
The Funding Opportunity Announcement (FOA) invites research grant applications from organizations/institutions that propose the development of novel radioligands for positron emission tomography (PET) or single photon emission computed tomography (SPECT) imaging in human brain, and that incorporate pilot or clinical feasibility evaluation in pre-clinical studies, model development, or clinical studies.

Inscrições:
R01: October 05, 2017.

Letter of Intent Due Date(s):
30 days prior to the application due date.

Data de expiração:
September 8, 2019.

Mais informações no site.

Objetivo:
The Funding Opportunity Announcement (FOA) invites research grant applications studying mechanisms of HIV-1 persistence and eradication strategies specifically focused on the central nervous system (CNS) in the context of viral suppression. Basic and translational research in domestic and international settings are of interest. Multidisciplinary research teams and collaborative alliances are encouraged but not required.

Inscrições:
R01: October 05, 2017.

Letter of Intent Due Date(s):
30 days prior to the application due date.

Data de expiração:
January 8, 2020.

Mais informações no site.

Objetivo:
Apresentar novas ideias e contribuições sobre os temas propostos, que propiciem o aperfeiçoamento do planejamento governamental, o aprimoramento das políticas públicas e ampliem o debate sobre as reformas econômicas para maior eficácia e efetividade das políticas e programas governamentais, além da melhoria do ambiente de negócios no Brasil.

Inscrições:
até dia 31 de outubro de 2017.

Mais informações no site.

Objetivo:
The Barth Syndrome Foundation (BSF) is the only worldwide volunteer organization dedicated to saving lives through education, advances in treatment, and finding a cure for Barth syndrome (BTHS). The Foundation strives to accelerate progress through collaboration between families and scientists. Also, it provides several ways to keep up-to-date about advances in science and medicine.

Inscrições:
até dia 31 de outubro de 2017.

Mais informações no site.